The reproductive and metabolic effect of rosiglitazone on Chinese women with polycystic ovarian syndrome—a double-blind randomized placebo-controlled study-Reference-Cited by-同舟云学术

The reproductive and metabolic effect of rosiglitazone on Chinese women with polycystic ovarian syndrome—a double-blind randomized placebo-controlled study

Published:2011-08 Issue:2 Volume:96 Page:445-451.e1
ISSN:0015-0282
Container-title:Fertility and Sterility
language:en
Short-container-title:Fertility and Sterility

Author:

Lam Po Mui,Tam Wing Hung,Wan Ma Ronald Ching,Cheung Lai Ping,Yuet Tsui Michelle Hang,Yip Tong Peter Chun,Chung Chow Francis Chun,Kei Lam Christopher Wai,Ming Chan Michael Ho,Ngor Chan Juliana Chung,Haines Christopher John

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Reproductive Medicine

Reference30 articles.

1. Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study;Knochenhauer;J Clin Endocrinol Metab,1998

2. The prevalence and features of the polycystic ovary syndrome in an unselected population;Azziz;J Clin Endocrinol Metab,2004

3. Role of hyperinsulinemia in the pathogenesis of the polycystic ovary syndrome, and its clinical implications;Nestler;Semin Reprod Endocrinol,1997

4. Insulin resistance, the metabolic syndrome, diabetes, and cardiovascular disease risk in women with PCOS;Teede;Endocrine,2006

5. Metabolic and ovarian effects of rosiglitazone treatment for 12 weeks in insulin-resistant women with polycystic ovary syndrome;Cataldo;Hum Reprod,2006

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Effect of Thiazolidinediones in Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis of Randomised Controlled Trials;Advances in Therapy;2024-04-29

2. Impact of pharmacological interventions on biochemical hyperandrogenemia in women with polycystic ovary syndrome: a systematic review and meta-analysis of randomised controlled trials;Archives of Gynecology and Obstetrics;2022-04-18

3. Impact of pharmacological interventions on anthropometric indices in women with polycystic ovary syndrome: A systematic review and meta‐analysis of randomized controlled trials;Clinical Endocrinology;2022-01-03

4. Role of Insulin-Sensitizing Drugs in PCOS Management;Polycystic Ovary Syndrome;2022

5. Comparing the individual effects of metformin and rosiglitazone and their combination in obese women with polycystic ovary syndrome: a randomized controlled trial;Fertility and Sterility;2020-01